Sudipta Chakraborty

Senior Manager, Clinical Trial Transparency, Biogen

Why Plain Language Summaries? 

Over the past 5 years, I’ve witnessed and admired a unified push towards increased transparency and disclosure for the general public. Patient-forward transparency not only builds and maintains public trust in clinical research, but also helps us all make informed healthcare decisions. I hope to see more and more open access and PLS initiatives in the near future!


Prior to joining the clinical trial transparency world, Dr. Chakraborty gained 6 years of experience in non-clinical biomedical research while obtaining her PhD in neuroscience. While working on her degree, Dr. Chakraborty also amassed extensive experience with the editing and writing of peer-reviewed research manuscripts, literature reviews, textbook chapters, and encyclopedia entries. Dr. Chakraborty now has over 5 years of experience writing clinical study reports (CSRs), protocols, patient-centric summaries of clinical study results, and clinical manuscripts, abstracts, and poster presentations. Her work has encompassed many therapeutic areas, most notably neurology, oncology, and immunology. Dr. Chakraborty’s passions lie with creating effective health communications and increasing health literacy in the general public. She currently manages a collaboration with the Center for Information and Study on Clinical Research Participation (CISCRP) to write plain language summaries of clinical study results. Dr. Chakraborty has developed a pipeline for writing patient-focused summaries of clinical study results for over 20 clients at now 2 different organizations. Through this leadership role, she communicates with and advises clients on plain language best practices and regulatory requirements. In addition, Dr. Chakraborty trains other writers in the areas of plain language summary development and both client and project management.